CVRX - CIK 0001235912
CVRx, Inc. trades as CVRX. In its fiscal 2025 annual report the company posted revenue of $56.65M, up 10.4% from the prior year and net income of -$53.31M. This page tracks CVRx, Inc. through 324 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 5 fiscal years CVRx, Inc.'s revenue grew from $6.05M to $56.65M, a compound annual growth rate of 56.4%. Net profit margin expanded from -233.1% to -94.1% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Quarterly report | 10-Q | 2026-05-12 |
| Major company event | 8-K | 2026-05-11 |
| Proxy materials | DEFA14A | 2026-04-20 |
| Proxy statement | DEF 14A | 2026-04-20 |
| Major company event | 8-K | 2026-04-13 |
| Insider trade | 4 | 2026-03-16 |
| Insider trade | 4 | 2026-03-04 |
| New insider ownership | 3 | 2026-03-04 |
The largest companies sharing CVRx, Inc.'s SEC industry classification (surgical & medical instruments & apparatus).
CVRx, Inc. reported revenue of $56.65M for fiscal year 2025, an increase of 10.4% year over year.
In its latest fiscal year CVRx, Inc. reported a net loss of $53.31M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.